查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2096819

獸醫疼痛管理市場－2026-2032年全球市場預測

Veterinary Pain Management Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，獸醫疼痛管理市場將成長至 44.7 億美元，複合年成長率為 10.28%。

主要市場統計數據
基準年 2025 22.5億美元
預計年份：2026年 24.5億美元
預測年份 2032 44.7億美元
複合年成長率 (%) 10.28%

獸醫疼痛管理正從支持性治療轉向實證臨床治療。

隨著臨床醫生、寵物飼主、畜牧相關人員和監管機構越來越重視動物福利、循證鎮痛和改善康復效果，獸醫疼痛管理正成為現代動物醫療保健的核心支柱。伴侶動物、馬匹和生產動物的疼痛已被公認為一種複雜的臨床疾病，需要在外科、整形外科、牙科、腫瘤科、神經科和慢性病科等各個領域進行及時評估、多方面治療和持續監測。此領域涵蓋非類固醇消炎劑、在允許的情況下使用鴉片類藥物、局部麻醉劑劑、α2促效劑、加巴噴丁類藥物、單株抗體、營養補充劑、再生醫學、物理療法、針灸、雷射療法和數位疼痛評估工具。

向多方面、預防性和以福利為導向的疼痛護理進行變革性轉變。

獸醫疼痛管理領域正經歷重大變革，其發展方向正朝著多方面鎮痛、個體化劑量設定和客觀疼痛評分的方向轉變。傳統上，疼痛管理主要依賴於種類有限的抗發炎藥物和鴉片類藥物，而現在則傾向於採用多層次的治療方案，以平衡療效、安全性、物種特異性代謝、合併症和疼痛持續時間。伴侶動物診所擴大採用系統性的疼痛評估量表、運動功能調查問卷、整形外科篩檢和術後監測作為治療方案選擇的指南。同時，轉診醫院也不斷提升其麻醉和復健能力，以應對複雜的病例。

人工智慧對疼痛檢測和臨床決策支援的累積影響。

人工智慧 (AI) 正透過改善疼痛的檢測、分類、監測和記錄方法，開始影響獸醫學中的疼痛管理。由於動物常常隱藏不適，且不同物種的臨床症狀各異，因此，人工智慧驅動的影像分析、步態評估、臉部辨識、姿勢追蹤和活動監測等技術有助於早期發現與疼痛相關的行為。這些技術在骨關節炎、術後恢復、馬跛行和畜群福利監測等領域尤其重要，因為在這些領域，動物運動、進食、休息或社交行為的細微變化都可能預示著疼痛加劇。

亞太地區、北美地區、拉丁美洲地區、歐洲地區以及中東和非洲地區的關鍵區域洞察

在亞太地區，由於伴侶動物數量的增加、獸醫服務利用率的提高以及不同生產系統中對牲畜福利的日益關注，獸醫疼痛管理正在迅速發展。中國、印度、日本、韓國和澳洲的都市區寵物飼養推動了對整形外科治療、老年動物疼痛管理、牙科手術和復健治療的需求成長，同時，全部區域大規模的牲畜存欄量也使得牛、豬、家禽和小反芻動物等動物的實用疼痛管理方案持續受到重視。獸醫基礎設施的差異仍然顯著，高度專業化的轉診服務集中在成熟的都市區，而農村地區和新興經濟體的醫療資源仍然有限。

東協、海灣合作理事會、歐盟、金磚國家、七國集團和北約的關鍵集團分析

隨著東南亞地區都市化活性化、中產階級寵物飼養量增加以及肉類生產規模擴大，東南亞國協對獸醫疼痛管理的關注度日益提高。主要城市的伴侶動物診所正在採用更有系統的手術全期和慢性疼痛管理技術，而畜牧業則在尋求經濟有效的鎮痛方法，以便應用於從大型農場到小規模系統。培訓、產品取得和標準化標準是推動這一領域發展的關鍵因素。

主要獸醫疼痛管理市場的關鍵國家特定洞察

美國憑藉著廣泛的專業護理、系統化的麻醉方案、復健服務以及老年伴侶動物慢性疼痛治療​​的強勁需求，在先進的獸醫疼痛管理實踐方面處於主導。加拿大也重視動物福利、術後鎮痛和負責任的處方，但在偏遠地區面臨地理上的交通不便。墨西哥正在都市區推動伴侶動物照護的現代化，同時仍需滿足大量的牲畜疼痛管理需求。巴西擁有龐大的伴侶動物數量以及大規模的牛、家禽和生豬養殖業，因此將寵物疼痛照護和生產動物的福利視為至關重要的問題。英國擁有成熟的獸醫專業、高度的寵物飼主參與度以及對動物福利的強烈期望，這支持了有記錄的疼痛評估和多方面的鎮痛治療。

為獸醫疼痛管理行業的領導者提供的實用建議

產業領導者應優先考慮以實證醫學為基礎、特異性物種的疼痛管理策略，並使其符合臨床指南、監管要求和現場獸醫工作流程。產品開發應著重於更安全、長效的止痛藥、非鴉片類替代藥物、針對貓和其他需要特殊代謝考量的物種的改良配方，以及適用於獸醫和現場使用的解決方案。教育仍然是至關重要的差異化因素。獸醫、獸醫技師、牲畜飼養員和寵物飼主需要關於疼痛識別、劑量依從性、監測、不利事件報告和後續護理的實用指導。

基於檢驗的臨床、監管和福利證據的調查方法。

獸醫疼痛管理的調查方法應結合二手資料研究、專家檢驗和結構化資料的檢驗。可靠的資訊來源包括同行評審的獸醫期刊、監管指南、獸醫協會資料、動物福利標準、藥物警戒文件、臨床實踐指南、公共衛生和農業資訊來源，以及關於鎮痛、麻醉、骨關節炎、康復和物種特異性疼痛行為的科學文獻。區域和國家層面的解讀應考慮獸醫基礎設施、動物族群統計數據、畜牧系統、藥品取得途徑、監管控制和福利要求。

結論：透過福利、證據和數位創新來推進獸醫疼痛管理。

獸醫疼痛管理正朝著數據驅動的綜合領域發展，為動物福利、臨床品質和長期照護效果奠定基礎。其主要驅動力包括多方面鎮痛、慢性疼痛的識別、老年寵物護理、牲畜福利要求以及人工智慧評估工具的逐步應用。區域差異依然顯著。成熟市場透過專業化、數位化整合和標準化流程取得進展，而新興市場則更注重可及性、可負擔性、培訓和可擴展的福利實踐。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 獸醫疼痛管理市場：依產品類型分類

  • 非類固醇消炎劑（NSAIDs）
    • 卡洛芬
    • 氟尼辛
    • 美洛昔康
    • 羅貝那昔布
  • 鴉片類藥物
    • 氫可酮
    • Buprenornhine
    • Fentanyl
  • 局部麻醉劑
    • Lidocaine
    • Bupivacaine
    • Ropivacaine

第8章：獸醫疼痛管理市場：依動物類型分類

  • 貓
  • 狗
  • 馬
  • 家畜

第9章 獸醫疼痛管理市場：依給藥途徑分類

  • 注射藥物
    • 肌肉內部
    • 靜脈
    • 皮下
  • 口服
  • 外用
    • 凝膠
    • 修補
    • 噴
  • 經皮給藥

第10章 獸醫疼痛管理市場：依通路分類

  • 直銷
  • 醫院藥房
  • 網路藥房
  • 零售藥房

第11章 獸醫疼痛管理市場：依最終用戶分類

  • 動物醫院
  • 學術研究機構
  • 畜牧場
  • 動物診所
  • 動物康復中心

第12章 獸醫疼痛管理市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章 獸醫疼痛管理市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 獸醫疼痛管理市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • Bimeda Holdings PLC
  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale SA
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Incorporated
  • Kyoritsu Seiyaku Corporation
  • Laboratorios Calier, SA
  • Merck & Co., Inc.
  • Neogen Corporation
  • Nextmune Holding BV
  • Norbrook Laboratories Limited
  • Orion Corporation
  • Parnell Pharmaceuticals Holdings Ltd.
  • PetVivo Holdings, Inc.
  • Phibro Animal Health Corporation
  • SeQuent Scientific Limited
  • Vetbiolix SAS
  • Vetcare Oy
  • Vetoquinol SA
  • VETRISCIENCE Laboratories
  • Virbac SA
  • Zoetis Inc.
  • Zomedica Corp.
Product Code: MRR-957C47F93EAD

The Veterinary Pain Management Market is projected to grow by USD 4.47 billion at a CAGR of 10.28% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.25 billion
Estimated Year [2026] USD 2.45 billion
Forecast Year [2032] USD 4.47 billion
CAGR (%) 10.28%

Veterinary Pain Management Moves From Supportive Care to Evidence-Based Clinical Priority

Veterinary pain management is becoming a core pillar of modern animal healthcare as clinicians, pet owners, livestock producers, and regulators place greater emphasis on animal welfare, evidence-based analgesia, and improved recovery outcomes. Pain in companion animals, equine patients, and production animals is now recognized as a complex clinical condition that requires timely assessment, multimodal treatment, and continuous monitoring across surgical, orthopedic, dental, oncologic, neurologic, and chronic disease settings. The field includes nonsteroidal anti-inflammatory drugs, opioids where permitted, local anesthetics, alpha-2 agonists, gabapentinoids, monoclonal antibodies, nutraceutical adjuncts, regenerative therapies, physical rehabilitation, acupuncture, laser therapy, and digital pain assessment tools.

Demand is being shaped by rising pet humanization, longer animal lifespans, higher prevalence of osteoarthritis and chronic mobility disorders, increased adoption of companion animal insurance in select countries, and stronger expectations for perioperative analgesia. In food-producing animals, welfare certification schemes, antimicrobial stewardship programs, and productivity considerations are encouraging better recognition and treatment of pain associated with lameness, castration, dehorning, calving, transport injury, and infectious or inflammatory conditions. Across veterinary practices, the strategic priority is shifting from episodic pain relief to integrated pain protocols that combine diagnostics, pharmacology, behavior assessment, rehabilitation, and owner education.

Transformative Shifts Toward Multimodal, Preventive, and Welfare-Driven Pain Care

The veterinary pain management landscape is undergoing a significant transformation as the profession moves toward multimodal analgesia, individualized dosing, and objective pain scoring. Traditional reliance on a narrow set of anti-inflammatory or opioid-based interventions is giving way to layered protocols that balance efficacy, safety, species-specific metabolism, comorbidities, and duration of pain. Companion animal clinics are increasingly using structured pain scales, mobility questionnaires, orthopedic screening, and postoperative monitoring to guide treatment selection, while referral hospitals are expanding anesthetic and rehabilitation capabilities for complex cases.

Regulatory and social pressures are also reshaping the field. Restrictions and oversight related to controlled substances are encouraging clinicians to optimize non-opioid pathways, regional anesthesia, local blocks, and long-acting therapeutics. At the same time, growing consumer awareness of animal discomfort has increased demand for chronic pain management in aging dogs, cats, and horses. In livestock systems, welfare standards and retail supply-chain requirements are reinforcing the importance of analgesia during routine husbandry procedures. Digital health platforms, wearable activity monitors, tele-triage tools, and electronic medical records are further enabling continuous assessment rather than one-time clinical observation. These shifts are creating a more protocol-driven, outcome-oriented environment in which pain recognition, documentation, and follow-up are central to quality veterinary care.

Cumulative Impact of Artificial Intelligence on Pain Detection and Clinical Decision Support

Artificial intelligence is beginning to influence veterinary pain management by improving how pain is detected, classified, monitored, and documented. Because animals often mask discomfort and clinical signs vary by species, AI-enabled image analysis, gait evaluation, facial expression recognition, posture tracking, and activity monitoring can support earlier identification of pain-related behavior. These technologies are particularly relevant in osteoarthritis, post-surgical recovery, equine lameness, and herd-level welfare monitoring, where subtle changes in movement, feeding, resting, or social behavior may indicate worsening pain.

AI also has a cumulative impact on clinical decision support. Integrated with electronic health records, diagnostic imaging, laboratory data, and owner-reported outcomes, AI tools can help standardize pain scoring, flag treatment gaps, and support follow-up scheduling. In livestock operations, machine vision and sensor-based analytics can assist in detecting lameness, injury, or abnormal behavior at scale, improving both welfare and operational efficiency. However, adoption depends on validation, explainability, cybersecurity, data quality, clinician oversight, and alignment with veterinary regulatory standards. AI is not replacing clinical judgment; it is strengthening pain recognition and enabling more consistent, data-informed intervention across diverse animal populations.

Key Regional Insights Across Asia-Pacific, North America, Latin America, Europe, Middle East, and Africa

Asia-Pacific is advancing rapidly in veterinary pain management due to expanding companion animal ownership, rising veterinary service utilization, and increasing attention to livestock welfare across diverse production systems. Urban pet ownership in China, India, Japan, South Korea, and Australia is supporting higher demand for orthopedic care, geriatric pain treatment, dental procedures, and rehabilitation, while large livestock populations across the region create ongoing need for practical analgesic protocols in cattle, swine, poultry, and small ruminants. Variation in veterinary infrastructure remains significant, with highly specialized referral care concentrated in mature urban markets and access gaps persisting in rural and emerging economies.

North America remains one of the most protocol-driven regions for veterinary pain management, supported by advanced companion animal care, broad availability of specialty practices, established animal welfare guidelines, and strong adoption of diagnostic imaging, rehabilitation, and chronic disease management. The United States and Canada show high clinical emphasis on perioperative analgesia, osteoarthritis management, dental pain control, and multimodal care, while Mexico is seeing growing modernization of companion animal clinics alongside livestock-focused welfare needs.

Latin America combines expanding pet healthcare demand with a strong production-animal base. Brazil and Mexico are key contributors to regional veterinary service development, with pain management priorities spanning companion animal surgery, equine care, cattle handling, and herd health. Access, affordability, and product availability vary considerably across markets, making education, practical dosing guidance, and scalable welfare protocols essential.

Europe is shaped by rigorous animal welfare expectations, mature veterinary education, and strong scrutiny of antimicrobial and controlled-substance use. Pain management practices emphasize documentation, preventive analgesia, rehabilitation, and compliance with welfare regulations across companion and farm animals. The region's clinical environment favors validated pain scales, responsible prescribing, and non-opioid adjunctive strategies.

The Middle East is experiencing growth in companion animal care, equine medicine, and veterinary infrastructure, particularly in urban centers and countries investing in advanced animal health services. Pain management needs are influenced by equine sports medicine, small animal surgery, and food-animal welfare modernization. Africa presents a heterogeneous landscape, with major pain management needs in livestock health, working animals, wildlife medicine, and expanding urban companion animal practice. Resource constraints, veterinary access, and supply-chain reliability remain central challenges, but welfare education and practical analgesia protocols are gaining importance.

Key Group Insights Across ASEAN, GCC, European Union, BRICS, G7, and NATO

ASEAN countries are seeing stronger interest in veterinary pain management as urbanization, middle-class pet ownership, and food-animal production intensify across Southeast Asia. Companion animal clinics in major cities are adopting more structured perioperative and chronic pain practices, while livestock sectors require cost-effective analgesic approaches that can be implemented within large-scale and smallholder systems. Training, product access, and harmonized standards are important enablers across the group.

The GCC is characterized by rising investment in companion animal services, equine care, falconry-related veterinary expertise, and modern livestock systems. Pain management adoption is supported by advanced clinics in major urban areas and demand for high-quality surgical, orthopedic, and sports medicine services. The European Union places strong emphasis on animal welfare, pharmacovigilance, responsible medicine use, and standardized veterinary practice. EU policy frameworks and professional guidelines encourage documented pain assessment, humane management of farm procedures, and careful control of analgesic use in food-producing animals.

BRICS economies represent a broad mix of high-growth companion animal markets, large livestock populations, and expanding veterinary infrastructure. China, India, Brazil, Russia, and South Africa share significant needs for scalable pain management across urban pet care and production-animal systems, although access and regulatory environments differ markedly. The G7 group reflects mature veterinary systems with extensive clinical specialization, strong research capacity, and widespread use of evidence-based protocols in companion animal surgery, osteoarthritis, oncology, dentistry, and rehabilitation. NATO countries overlap substantially with developed veterinary markets in North America and Europe, where defense-related working animals, service dogs, equine programs, and public-sector veterinary standards add further relevance to pain recognition, trauma care, and rehabilitation.

Key Country Insights Across Major Veterinary Pain Management Markets

The United States leads in advanced veterinary pain management practices through widespread specialty care, structured anesthesia protocols, rehabilitation services, and strong demand for chronic pain treatment in aging companion animals. Canada shows similar emphasis on welfare, postoperative analgesia, and responsible prescribing, with geographic access challenges in remote areas. Mexico is modernizing companion animal care in urban centers while maintaining significant livestock-related analgesia needs. Brazil combines a large companion animal population with major cattle, poultry, and swine industries, making both pet pain care and production-animal welfare important. The United Kingdom has a mature veterinary profession, high pet ownership engagement, and strong welfare expectations that support documented pain assessment and multimodal analgesia.

Germany, France, Italy, and Spain show advanced European approaches to animal welfare, preventive pain control, and responsible medicine use across companion and farm animals. Germany is notable for rigorous veterinary standards and strong clinical infrastructure, while France emphasizes both companion animal medicine and livestock welfare. Italy and Spain are important markets for small animal surgery, equine medicine, and geriatric pet care. Russia presents a mixed environment, with advanced veterinary services in major cities and uneven access across wider regions. China is experiencing rapid expansion in urban pet healthcare, with increasing demand for orthopedic, dental, and chronic pain solutions, alongside large-scale livestock health needs. India has a dual profile: accelerating companion animal care in metropolitan areas and extensive requirements for livestock, working animal, and rural veterinary pain management.

Japan has a highly developed companion animal care environment, supported by an aging pet population and demand for chronic disease and mobility management. Australia combines advanced small animal medicine with strong livestock and equine sectors, where welfare-driven pain protocols are increasingly important. South Korea is expanding veterinary specialization, pet insurance awareness, and advanced companion animal services, supporting broader adoption of pain assessment, surgical analgesia, and long-term mobility care.

Actionable Recommendations for Veterinary Pain Management Industry Leaders

Industry leaders should prioritize evidence-based, species-specific pain management strategies that align with clinical guidelines, regulatory expectations, and real-world veterinary workflows. Product development should focus on safer long-duration analgesics, non-opioid alternatives, improved formulations for cats and other species with unique metabolic considerations, and solutions suitable for both clinic-based and field-based use. Education remains a critical differentiator: veterinarians, technicians, livestock handlers, and pet owners need practical guidance on pain recognition, dosing adherence, monitoring, adverse-event reporting, and follow-up care.

Organizations should invest in multimodal care ecosystems that integrate pharmaceuticals, diagnostics, rehabilitation, digital monitoring, and outcome tracking. Partnerships with veterinary educators, welfare bodies, and professional associations can strengthen adoption of validated pain scales and standardized protocols. For emerging markets, affordability, cold-chain resilience, packaging flexibility, and local training can improve access. For mature markets, differentiation should focus on clinical evidence, safety profiles, ease of administration, compliance support, and digital integration. Leaders should also prepare for the growing role of AI by ensuring data integrity, ethical use, validation, and clinician-centered design.

Research Methodology Based on Verified Clinical, Regulatory, and Welfare Evidence

The research methodology for analyzing veterinary pain management should combine secondary research, expert validation, and structured data triangulation. Reliable inputs include peer-reviewed veterinary journals, regulatory guidance, veterinary medical association resources, animal welfare standards, pharmacovigilance documentation, clinical practice guidelines, public health and agriculture sources, and scientific literature on analgesia, anesthesia, osteoarthritis, rehabilitation, and species-specific pain behavior. Regional and country-level interpretation should consider veterinary infrastructure, animal demographics, livestock systems, medicine access, regulatory controls, and welfare requirements.

Primary validation should include perspectives from veterinarians, anesthesiologists, surgeons, rehabilitation specialists, livestock health experts, animal welfare professionals, distributors, and regulatory specialists. Insights should be assessed through qualitative consistency checks rather than unsupported numerical assumptions. Because this executive summary avoids market sizing, market share, and forecasting, the emphasis is placed on verified clinical trends, adoption drivers, regulatory context, technology impact, and strategic implications. Data triangulation across scientific evidence, practitioner experience, and policy frameworks helps ensure balanced, decision-ready conclusions.

Conclusion: Veterinary Pain Management Advances Through Welfare, Evidence, and Digital Innovation

Veterinary pain management is evolving into an integrated, data-informed discipline that supports animal welfare, clinical quality, and long-term care outcomes. The strongest momentum is coming from multimodal analgesia, chronic pain recognition, geriatric pet care, livestock welfare requirements, and the gradual introduction of AI-enabled assessment tools. Regional differences remain important: mature markets are advancing through specialization, digital integration, and standardized protocols, while emerging markets are focused on access, affordability, training, and scalable welfare practices.

For industry participants, success will depend on aligning innovation with veterinary realities: species-specific safety, ease of administration, regulatory compliance, measurable outcomes, and education for both professionals and animal owners. As expectations for humane and evidence-based care continue to rise, veterinary pain management will remain a critical area of clinical advancement across companion animals, equine medicine, livestock production, working animals, and wildlife care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. New Revenue Opportunities
  • 3.5. Next-Generation Business Models
  • 3.6. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Veterinary Pain Management Market, by Product Type

  • 7.1. Introduction
  • 7.2. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
    • 7.2.1. Carprofen
    • 7.2.2. Flunixin
    • 7.2.3. Meloxicam
    • 7.2.4. Robenacoxib
  • 7.3. Opioids
    • 7.3.1. Morphine
    • 7.3.2. Buprenorphine
    • 7.3.3. Fentanyl
  • 7.4. Local Anesthetics
    • 7.4.1. Lidocaine
    • 7.4.2. Bupivacaine
    • 7.4.3. Ropivacaine

8. Veterinary Pain Management Market, by Animal Type

  • 8.1. Introduction
  • 8.2. Cats
  • 8.3. Dogs
  • 8.4. Equine
  • 8.5. Livestock

9. Veterinary Pain Management Market, by Route Of Administration

  • 9.1. Introduction
  • 9.2. Injectable
    • 9.2.1. Intramuscular
    • 9.2.2. Intravenous
    • 9.2.3. Subcutaneous
  • 9.3. Oral
  • 9.4. Topical
    • 9.4.1. Gels
    • 9.4.2. Patches
    • 9.4.3. Sprays
  • 9.5. Transdermal

10. Veterinary Pain Management Market, by Distribution Channel

  • 10.1. Introduction
  • 10.2. Direct Distribution
  • 10.3. Hospital Pharmacies
  • 10.4. Online Pharmacies
  • 10.5. Retail Pharmacies

11. Veterinary Pain Management Market, by End User

  • 11.1. Introduction
  • 11.2. Veterinary Hospitals
  • 11.3. Academic & Research Institutes
  • 11.4. Livestock Farms
  • 11.5. Veterinary Clinics
  • 11.6. Animal Rehabilitation Centers

12. Veterinary Pain Management Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. North America
  • 12.3. Latin America
  • 12.4. Europe
  • 12.5. Middle East
  • 12.6. Africa

13. Veterinary Pain Management Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Veterinary Pain Management Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2025
  • 15.2. FPNV Positioning Matrix, 2025
  • 15.3. Market Concentration Analysis, 2025
    • 15.3.1. Concentration Ratio (CR)
    • 15.3.2. Herfindahl Hirschman Index (HHI)
  • 15.4. Recent Developments & Impact Analysis, 2025
  • 15.5. Product Portfolio Analysis, 2025
  • 15.6. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Bimeda Holdings PLC
  • 16.2. Boehringer Ingelheim International GmbH
  • 16.3. Ceva Sante Animale S.A.
  • 16.4. Dechra Pharmaceuticals PLC
  • 16.5. Elanco Animal Health Incorporated
  • 16.6. Kyoritsu Seiyaku Corporation
  • 16.7. Laboratorios Calier, S.A.
  • 16.8. Merck & Co., Inc.
  • 16.9. Neogen Corporation
  • 16.10. Nextmune Holding B.V.
  • 16.11. Norbrook Laboratories Limited
  • 16.12. Orion Corporation
  • 16.13. Parnell Pharmaceuticals Holdings Ltd.
  • 16.14. PetVivo Holdings, Inc.
  • 16.15. Phibro Animal Health Corporation
  • 16.16. SeQuent Scientific Limited
  • 16.17. Vetbiolix SAS
  • 16.18. Vetcare Oy
  • 16.19. Vetoquinol S.A.
  • 16.20. VETRISCIENCE Laboratories
  • 16.21. Virbac S.A.
  • 16.22. Zoetis Inc.
  • 16.23. Zomedica Corp.

LIST OF FIGURES

  • FIGURE 1. GLOBAL VETERINARY PAIN MANAGEMENT MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL VETERINARY PAIN MANAGEMENT MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL VETERINARY PAIN MANAGEMENT MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL VETERINARY PAIN MANAGEMENT MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 7. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 23. GLOBAL VETERINARY PAIN MANAGEMENT MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

LIST OF TABLES

  • TABLE 1. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CARPROFEN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CARPROFEN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL CARPROFEN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL FLUNIXIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL FLUNIXIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL FLUNIXIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MELOXICAM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MELOXICAM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MELOXICAM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ROBENACOXIB MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ROBENACOXIB MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ROBENACOXIB MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL OPIOIDS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL OPIOIDS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL OPIOIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MORPHINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MORPHINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL MORPHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BUPRENORPHINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL BUPRENORPHINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL BUPRENORPHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL FENTANYL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL FENTANYL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL FENTANYL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL LOCAL ANESTHETICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL LOCAL ANESTHETICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL LOCAL ANESTHETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL LIDOCAINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL LIDOCAINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL LIDOCAINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BUPIVACAINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL BUPIVACAINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL BUPIVACAINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ROPIVACAINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ROPIVACAINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ROPIVACAINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CATS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CATS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CATS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL DOGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL DOGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL DOGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL EQUINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL EQUINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL EQUINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL LIVESTOCK MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL LIVESTOCK MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL LIVESTOCK MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL INJECTABLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL INJECTABLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL INJECTABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL INTRAMUSCULAR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL INTRAMUSCULAR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL INTRAMUSCULAR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL INTRAVENOUS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL INTRAVENOUS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL INTRAVENOUS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL SUBCUTANEOUS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL SUBCUTANEOUS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL SUBCUTANEOUS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ORAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ORAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ORAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL TOPICAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL TOPICAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL TOPICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL GELS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL GELS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL GELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL PATCHES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL PATCHES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL PATCHES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL SPRAYS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL SPRAYS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL SPRAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL TRANSDERMAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL TRANSDERMAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL TRANSDERMAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL DIRECT DISTRIBUTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL DIRECT DISTRIBUTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL DIRECT DISTRIBUTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL HOSPITAL PHARMACIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL HOSPITAL PHARMACIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL HOSPITAL PHARMACIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL VETERINARY HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL VETERINARY HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL VETERINARY HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL LIVESTOCK FARMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL LIVESTOCK FARMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL LIVESTOCK FARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL VETERINARY CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL VETERINARY CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL VETERINARY CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL ANIMAL REHABILITATION CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL ANIMAL REHABILITATION CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL ANIMAL REHABILITATION CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2032 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2032 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC VETERINARY PAIN MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. NORTH AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 136. NORTH AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 137. NORTH AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 138. NORTH AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 144. LATIN AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 146. LATIN AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 147. LATIN AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 148. LATIN AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 149. LATIN AMERICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE VETERINARY PAIN MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE VETERINARY PAIN MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE VETERINARY PAIN MANAGEMENT MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE VETERINARY PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE VETERINARY PAIN MANAGEMENT MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE VETERINARY PAIN MANAGEMENT MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE VETERINARY PAIN MANAGEMENT MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE VETERINARY PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE VETERINARY PAIN MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST VETERINARY PAIN MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 162. MIDDLE EAST VETERINARY PAIN MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. MIDDLE EAST VETERINARY PAIN MANAGEMENT MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST VETERINARY PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST VETERINARY PAIN MANAGEMENT MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 166. MIDDLE EAST VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 168. MIDDLE EAST VETERINARY PAIN MANAGEMENT MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST VETERINARY PAIN MANAGEMENT MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 170. MIDDLE EAST VETERINARY PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST VETERINARY PAIN MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 172. AFRICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 173. AFRICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. AFRICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2032 (USD MILLION)
  • TABLE 175. AFRICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2032 (USD MILLION)
  • TABLE 176. AFRICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 177. AFRICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 179. AFRICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 180. AFRICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 181. AFRICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 182. AFRICA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 183. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 184. ASEAN VETERINARY PAIN MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 185. ASEAN VETERINARY PAIN MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. ASEAN VETERINARY PAIN MANAGEMENT MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2032 (USD MILLION)
  • TABLE 187. ASEAN VETERINARY PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2032 (USD MILLION)
  • TABLE 188. ASEAN VETERINARY PAIN MANAGEMENT MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 189. ASEAN VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. ASEAN VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 191. ASEAN VETERINARY PAIN MANAGEMENT MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 192. ASEAN VETERINARY PAIN MANAGEMENT MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 193. ASEAN VETERINARY PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 194. ASEAN VETERINARY PAIN MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 195. GCC VETERINARY PAIN MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 196. GCC VETERINARY PAIN MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. GCC VETERINARY PAIN MANAGEMENT MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2032 (USD MILLION)
  • TABLE 198. GCC VETERINARY PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2032 (USD MILLION)
  • TABLE 199. GCC VETERINARY PAIN MANAGEMENT MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 200. GCC VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 201. GCC VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 202. GCC VETERINARY PAIN MANAGEMENT MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 203. GCC VETERINARY PAIN MANAGEMENT MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 204. GCC VETERINARY PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 205. GCC VETERINARY PAIN MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPEAN UNION VETERINARY PAIN MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPEAN UNION VETERINARY PAIN MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPEAN UNION VETERINARY PAIN MANAGEMENT MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2032 (USD MILLION)
  • TABLE 209. EUROPEAN UNION VETERINARY PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPEAN UNION VETERINARY PAIN MANAGEMENT MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPEAN UNION VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPEAN UNION VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPEAN UNION VETERINARY PAIN MANAGEMENT MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPEAN UNION VETERINARY PAIN MANAGEMENT MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPEAN UNION VETERINARY PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPEAN UNION VETERINARY PAIN MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 217. BRICS VETERINARY PAIN MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 218. BRICS VETERINARY PAIN MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. BRICS VETERINARY PAIN MANAGEMENT MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2032 (USD MILLION)
  • TABLE 220. BRICS VETERINARY PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2032 (USD MILLION)
  • TABLE 221. BRICS VETERINARY PAIN MANAGEMENT MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 222. BRICS VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 223. BRICS VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 224. BRICS VETERINARY PAIN MANAGEMENT MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 225. BRICS VETERINARY PAIN MANAGEMENT MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 226. BRICS VETERINARY PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 227. BRICS VETERINARY PAIN MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 228. G7 VETERINARY PAIN MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 229. G7 VETERINARY PAIN MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 230. G7 VETERINARY PAIN MANAGEMENT MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2032 (USD MILLION)
  • TABLE 231. G7 VETERINARY PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2032 (USD MILLION)
  • TABLE 232. G7 VETERINARY PAIN MANAGEMENT MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 233. G7 VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 234. G7 VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 235. G7 VETERINARY PAIN MANAGEMENT MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 236. G7 VETERINARY PAIN MANAGEMENT MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 237. G7 VETERINARY PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 238. G7 VETERINARY PAIN MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 239. NATO VETERINARY PAIN MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 240. NATO VETERINARY PAIN MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 241. NATO VETERINARY PAIN MANAGEMENT MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2032 (USD MILLION)
  • TABLE 242. NATO VETERINARY PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2032 (USD MILLION)
  • TABLE 243. NATO VETERINARY PAIN MANAGEMENT MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 244. NATO VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 245. NATO VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 246. NATO VETERINARY PAIN MANAGEMENT MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 247. NATO VETERINARY PAIN MANAGEMENT MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 248. NATO VETERINARY PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 249. NATO VETERINARY PAIN MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 250. GLOBAL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 251. UNITED STATES VETERINARY PAIN MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 252. UNITED STATES VETERINARY PAIN MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 253. UNITED STATES VETERINARY PAIN MANAGEMENT MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2032 (USD MILLION)
  • TABLE 254. UNITED STATES VETERINARY PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2032 (USD MILLION)
  • TABLE 255. UNITED STATES VETERINARY PAIN MANAGEMENT MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 256. UNITED STATES VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 257. UNITED STATES VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 258. UNITED STATES VETERINARY PAIN MANAGEMENT MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 259. UNITED STATES VETERINARY PAIN MANAGEMENT MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 260. UNITED STATES VETERINARY PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 261. UNITED STATES VETERINARY PAIN MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 262. CANADA VETERINARY PAIN MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 263. CANADA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 264. CANADA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2032 (USD MILLION)
  • TABLE 265. CANADA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2032 (USD MILLION)
  • TABLE 266. CANADA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 267. CANADA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 268. CANADA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 269. CANADA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 270. CANADA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 271. CANADA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 272. CANADA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 273. MEXICO VETERINARY PAIN MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 274. MEXICO VETERINARY PAIN MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 275. MEXICO VETERINARY PAIN MANAGEMENT MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2032 (USD MILLION)
  • TABLE 276. MEXICO VETERINARY PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2032 (USD MILLION)
  • TABLE 277. MEXICO VETERINARY PAIN MANAGEMENT MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 278. MEXICO VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 279. MEXICO VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 280. MEXICO VETERINARY PAIN MANAGEMENT MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 281. MEXICO VETERINARY PAIN MANAGEMENT MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 282. MEXICO VETERINARY PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 283. MEXICO VETERINARY PAIN MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 284. BRAZIL VETERINARY PAIN MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 285. BRAZIL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 286. BRAZIL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2032 (USD MILLION)
  • TABLE 287. BRAZIL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2032 (USD MILLION)
  • TABLE 288. BRAZIL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 289. BRAZIL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 290. BRAZIL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 291. BRAZIL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 292. BRAZIL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 293. BRAZIL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 294. BRAZIL VETERINARY PAIN MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 295. UNITED KINGDOM VETERINARY PAIN MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 296. UNITED KINGDOM VETERINARY PAIN MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 297. UNITED KINGDOM VETERINARY PAIN MANAGEMENT MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2032 (USD MILLION)
  • TABLE 298. UNITED KINGDOM VETERINARY PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2032 (USD MILLION)
  • TABLE 299. UNITED KINGDOM VETERINARY PAIN MANAGEMENT MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 300. UNITED KINGDOM VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 301. UNITED KINGDOM VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 302. UNITED KINGDOM VETERINARY PAIN MANAGEMENT MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 303. UNITED KINGDOM VETERINARY PAIN MANAGEMENT MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 304. UNITED KINGDOM VETERINARY PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 305. UNITED KINGDOM VETERINARY PAIN MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 306. GERMANY VETERINARY PAIN MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 307. GERMANY VETERINARY PAIN MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 308. GERMANY VETERINARY PAIN MANAGEMENT MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2032 (USD MILLION)
  • TABLE 309. GERMANY VETERINARY PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2032 (USD MILLION)
  • TABLE 310. GERMANY VETERINARY PAIN MANAGEMENT MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 311. GERMANY VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 312. GERMANY VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 313. GERMANY VETERINARY PAIN MANAGEMENT MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 314. GERMANY VETERINARY PAIN MANAGEMENT MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 315. GERMANY VETERINARY PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 316. GERMANY VETERINARY PAIN MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 317. FRANCE VETERINARY PAIN MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 318. FRANCE VETERINARY PAIN MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 319. FRANCE VETERINARY PAIN MANAGEMENT MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2032 (USD MILLION)
  • TABLE 320. FRANCE VETERINARY PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2032 (USD MILLION)
  • TABLE 321. FRANCE VETERINARY PAIN MANAGEMENT MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 322. FRANCE VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 323. FRANCE VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 324. FRANCE VETERINARY PAIN MANAGEMENT MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 325. FRANCE VETERINARY PAIN MANAGEMENT MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 326. FRANCE VETERINARY PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 327. FRANCE VETERINARY PAIN MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 328. RUSSIA VETERINARY PAIN MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 329. RUSSIA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 330. RUSSIA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2032 (USD MILLION)
  • TABLE 331. RUSSIA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2032 (USD MILLION)
  • TABLE 332. RUSSIA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 333. RUSSIA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 334. RUSSIA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 335. RUSSIA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 336. RUSSIA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 337. RUSSIA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 338. RUSSIA VETERINARY PAIN MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 339. ITALY VETERINARY PAIN MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 340. ITALY VETERINARY PAIN MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 341. ITALY VETERINARY PAIN MANAGEMENT MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2032 (USD MILLION)
  • TABLE 342. ITALY VETERINARY PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2032 (USD MILLION)
  • TABLE 343. ITALY VETERINARY PAIN MANAGEMENT MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 344. ITALY VETERINARY